CAPRELSA®( vandetanib )

Drug CAPRELSA® vandetanib Caprelsa Overview This is a summary of the European public assessment report (EPAR) for Caprelsa. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Caprelsa. How is Caprelsa used? […]

INTRON A® (interferon alfa-2b)

Drug INTRON A® interferon alfa-2b intron A Overview This is a summary of the European public assessment report (EPAR) for IntronA. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for IntronA. How is Intron A […]

IMLYGIC® (talimogene laherparepvec)

Drug IMLYGIC® talimogene laherparepvec Imlygic Overview This is a summary of the European public assessment report (EPAR) for Imlygic. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Imlygic. For practical information about using […]

ZELBORAF® (vemurafenib)

Drug ZELBORAF® vemurafenib Zelboraf Overview Zelboraf is a cancer medicine used to treat adults with melanoma (a type of skin cancer) that has spread to other parts of the body or cannot be surgically removed. Zelboraf is only for patients whose melanoma tumour cells have a specific mutation (genetic change) called ‘BRAF V600’. Zelboraf contains […]

MEKINIST® (trametinib)

Drug MEKINIST® trametinib Mekinist Overview Mekinist is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) in their genes called ‘BRAF V600’. It is used for the treatment of: melanoma (a skin cancer) that has spread or cannot be removed surgically. Mekinist is used on its own or […]

TAFINLAR® (dabrafenib)

Drug TAFLINAR® dabrafenib Tafinlar Overview Tafinlar is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) called ‘BRAF V600’. It is used for the treatment of: melanoma (a skin cancer) that has spread or cannot be removed surgically. Tafinlar is used on its own or in combination with […]

YERVOY® (ipilimumab)

Drug YERVOY® ipilimumab Yervoy Overview Yervoy is a cancer medicine used in adults and adolescents from 12 years of age with advanced melanoma (a type of skin cancer) and in adults with advanced renal cell carcinoma (a kidney cancer). Yervoy is usually used in combination with another medicine, nivolumab, but can also be used on […]

KEYTRUDA® (pembrolizumab)

Drug KEYTRUDA® Pembrolizumab Keytruda Overview Keytruda is a cancer medicine used to treat: melanoma, a skin cancer, non-small cell lung cancer (NSCLC), a type of lung cancer, classical Hodgkin lymphoma, a cancer of the white blood cells, urothelial cancer, a cancer of the bladder and urinary tract, a cancer affecting the head and neck known […]